HUCK OTRANTO CAMARGO has been deepening for years its relationship with the chemical and pharmaceutical industry, an experience that gives it the capabilities to respond to the most diverse demands of clients acting in this sector.
We have a highly qualified and specialized team prepared to provide legal advice in the consulting, regulatory and litigation areas.
In the consulting area, HUCK OTRANTO CAMARGO assists clients of the chemical and pharmaceutical industry in mergers and acquisitions (M&A). The experience gained with M&A transactions allows us to carefully and accurately pinpoint and address the most sensitive aspects of negotiations involving the acquisition of pharmaceutical companies, such as product protection, manufacturing processes and other matters of interest to the industry.
We are well equipped to assess and deal with regulatory matters, from follow-up on industrial property registration to, and especially, assistance in the process of registration of medical drugs and crop protection products before the health and environmental authorities, including regulation of medical drug prices.
We assist and advise clients of the chemical and pharmaceutical industry in their interface with public authorities and its various forms of contact and interaction: we provide consulting services and act in litigations related to bidding procedures, analyzing documents and advising our clients in the execution of administrative agreements and conventions preceded by public offers in public-private partnerships and product development partnerships (PDPs).
HUCK OTRANTO CAMARGO has extensive experience in legal proceedings related to patent infringement, as well as in lawsuits brought to curb unfair competition, for undue use of trademark rights, and for redress of losses.
We also have expertise in representing laboratories and chemical and pharmaceutical industries in lawsuits involving termination of distribution and agency agreements and in individual and collective lawsuits based on consumer law.